208 related articles for article (PubMed ID: 25866032)
21. Use of stents for small coronary arteries. Results of the Multi-Link 2.5 Portuguese Registry.
Seabra-Gomes R; Farto eAbreu P; Marques AL; Pereira H; da Cunha JA; Carvalho H; Ribeiro VG; Garcia LM; Mourão L; dos Santos LP; Providência L; Figueiredo L; Almeida M; Cavaco D
Rev Port Cardiol; 2001 Sep; 20(9):819-37. PubMed ID: 11763595
[TBL] [Abstract][Full Text] [Related]
22. Initial Experience With GlideAssist to Facilitate Advancement of Orbital Atherectomy Prior to Plaque Modification of Severely Calcified Coronary Artery Lesions.
Lee MS; Shlofmitz E; Rha SW; Shlofmitz R
J Invasive Cardiol; 2019 Nov; 31(11):331-334. PubMed ID: 31671058
[TBL] [Abstract][Full Text] [Related]
23. [Safety and efficacy of rotational atherectomy followed by drug-eluting stenting for treating patients with heavily calcified coronary lesions].
Li Q; Liu J; Lu MY; Ma YL; Zhao H; Ding RJ; Liu CF; Wang WM
Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Jun; 41(6):457-61. PubMed ID: 24113035
[TBL] [Abstract][Full Text] [Related]
24. Rotational atherectomy for left main coronary artery disease in octogenarians: transradial approach in a tertiary center and literature review.
Dahdouh Z; Roule V; Dugué AE; Sabatier R; Lognoné T; Grollier G
J Interv Cardiol; 2013 Apr; 26(2):173-82. PubMed ID: 23557587
[TBL] [Abstract][Full Text] [Related]
25. Orbital atherectomy for the treatment of severely calcified coronary lesions: evidence, technique, and best practices.
Shlofmitz E; Martinsen BJ; Lee M; Rao SV; Généreux P; Higgins J; Chambers JW; Kirtane AJ; Brilakis ES; Kandzari DE; Sharma SK; Shlofmitz R
Expert Rev Med Devices; 2017 Nov; 14(11):867-879. PubMed ID: 28945162
[TBL] [Abstract][Full Text] [Related]
26. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
[TBL] [Abstract][Full Text] [Related]
27. The Frontier stent registry: safety and feasibility of a novel dedicated stent for the treatment of bifurcation coronary artery lesions.
Lefèvre T; Ormiston J; Guagliumi G; Schultheiss HP; Quilliet L; Reimers B; Brunel P; Wijns W; Buettner HJ; Hartmann F; Veldhof S; Miquel K; Su X; van der Giessen WJ
J Am Coll Cardiol; 2005 Aug; 46(4):592-8. PubMed ID: 16098421
[TBL] [Abstract][Full Text] [Related]
28. Impact of diabetes mellitus on procedural and one year clinical outcomes following treatment of severely calcified coronary lesions with the orbital atherectomy system: A subanalysis of the ORBIT II study.
Lee MS; Martinsen BJ; Lee AC; Behrens AN; Shlofmitz RA; Kim CY; Chambers JW
Catheter Cardiovasc Interv; 2018 May; 91(6):1018-1025. PubMed ID: 28733974
[TBL] [Abstract][Full Text] [Related]
29. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
[TBL] [Abstract][Full Text] [Related]
30. Safety and Feasibility of the Coronary Orbital Atherectomy System via the Transradial Approach.
Ruisi M; Zachariah J; Ratcliffe J; Lala M; Ruisi P; Huang Y; Diwan R; Daggubati R; Patel T; Kwan TW
J Invasive Cardiol; 2015 Nov; 27(11):E252-5. PubMed ID: 26524211
[TBL] [Abstract][Full Text] [Related]
31. Clinical outcomes of first- and second-generation drug-eluting stents in patients undergoing rotational atherectomy for heavily calcified coronary lesions.
Tian W; Mahmoudi M; Lhermusier T; Pendyala LK; Kiramijyan S; Saar M; Ota H; Chen F; Torguson R; Suddath WO; Satler LF; Pichard AD; Waksman R
Cardiovasc Revasc Med; 2015; 16(3):147-50. PubMed ID: 25977225
[TBL] [Abstract][Full Text] [Related]
32. One-Year Outcomes of Orbital Atherectomy of Long, Diffusely Calcified Coronary Artery Lesions.
Lee MS; Shlofmitz E; Lluri G; Park KW; Hollowed J; Shlofmitz R
J Invasive Cardiol; 2018 Jun; 30(6):230-233. PubMed ID: 29799426
[TBL] [Abstract][Full Text] [Related]
33. Incidence of Bradycardia and Outcomes of Patients Who Underwent Orbital Atherectomy Without a Temporary Pacemaker.
Lee MS; Nguyen H; Shlofmitz R
J Invasive Cardiol; 2017 Feb; 29(2):59-62. PubMed ID: 28145873
[TBL] [Abstract][Full Text] [Related]
34. 5-year results of a randomized comparison of XIENCE V everolimus-eluting and TAXUS paclitaxel-eluting stents: final results from the SPIRIT III trial (clinical evaluation of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions).
Gada H; Kirtane AJ; Newman W; Sanz M; Hermiller JB; Mahaffey KW; Cutlip DE; Sudhir K; Hou L; Koo K; Stone GW
JACC Cardiovasc Interv; 2013 Dec; 6(12):1263-6. PubMed ID: 24239202
[TBL] [Abstract][Full Text] [Related]
35. Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 5 years follow-up from the randomized DEDICATION trial (Drug Elution and Distal Protection in Acute Myocardial Infarction).
Holmvang L; Kelbæk H; Kaltoft A; Thuesen L; Lassen JF; Clemmensen P; Kløvgaard L; Engstrøm T; Bøtker HE; Saunamäki K; Krusell LR; Jørgensen E; Tilsted HH; Christiansen EH; Ravkilde J; Køber L; Kofoed KF; Terkelsen CJ; Helqvist S
JACC Cardiovasc Interv; 2013 Jun; 6(6):548-53. PubMed ID: 23683734
[TBL] [Abstract][Full Text] [Related]
36. Outcomes of Orbital Atherectomy in Severely Calcified Small (2.5 mm) Coronary Artery Vessels.
Lee MS; Shlofmitz E; Shlofmitz R
J Invasive Cardiol; 2018 Aug; 30(8):310-314. PubMed ID: 30068786
[TBL] [Abstract][Full Text] [Related]
37. Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
Dangas GD; Serruys PW; Kereiakes DJ; Hermiller J; Rizvi A; Newman W; Sudhir K; Smith RS; Cao S; Theodoropoulos K; Cutlip DE; Lansky AJ; Stone GW
JACC Cardiovasc Interv; 2013 Sep; 6(9):914-22. PubMed ID: 24050859
[TBL] [Abstract][Full Text] [Related]
38. Results and long-term predictors of adverse clinical events after elective percutaneous interventions on unprotected left main coronary artery.
Takagi T; Stankovic G; Finci L; Toutouzas K; Chieffo A; Spanos V; Liistro F; Briguori C; Corvaja N; Albero R; Sivieri G; Paloschi R; Di Mario C; Colombo A
Circulation; 2002 Aug; 106(6):698-702. PubMed ID: 12163430
[TBL] [Abstract][Full Text] [Related]
39. Acute outcomes after coronary orbital atherectomy at a single center without on-site surgical backup: An experience in diabetics versus non-diabetics.
Whitbeck MG; Dewar J; Behrens AN; Watkins J; Martinsen BJ
Cardiovasc Revasc Med; 2018 Sep; 19(6S):12-15. PubMed ID: 29804796
[TBL] [Abstract][Full Text] [Related]
40. Impact of age following treatment of severely calcified coronary lesions with the orbital atherectomy system: 3-year follow-up.
Lee MS; Shlofmitz RA; Martinsen BJ; Sethi S; Chambers JW
Cardiovasc Revasc Med; 2018 Sep; 19(6):655-659. PubMed ID: 29452841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
